TORONTO, May 8, 2026, 11:06 EDT
Xanadu Quantum Technologies stock slid Friday morning, slipping 6.16% to $16.31 as of 10:49 a.m. ET, according to Finviz. This comes just a day after Tradr ETFs rolled out a 2x long fund linked to the recently listed Canadian quantum computing firm. Earlier in the week, a resale prospectus put close to 294 million shares in focus for investors.
The clock’s ticking for Xanadu, which is rapidly shifting from a low-profile public stock to a name with outsized price swings. The Tradr 2X Long XNDU Daily ETF—listed on Cboe under XNDX—targets double the daily returns of Xanadu shares. Leveraged ETFs like this one rely on borrowing or derivatives to amplify single-day moves, catering mostly to traders looking for quick action, not the sit-tight crowd.
Supply is the real drag here. According to a U.S. prospectus, selling securityholders could unload as many as 293,655,720 Class B subordinate voting shares—this tally includes those linked to converted multiple-voting stock, private placements, and founder shares. Xanadu won’t pocket any proceeds from these resales, aside from what comes in if certain warrants are exercised for cash.
The financial calendar brings another key date soon: Xanadu plans to release its first-quarter numbers for the period ending March 31 after the bell on May 14. Management will hold a conference call at 4:30 p.m. EDT to go over the results and talk through the outlook.
Xanadu wrapped up its merger with Crane Harbor Acquisition Corp. on March 26, locking in a US$275 million PIPE deal. Class B shares were slated to debut on both Nasdaq and the Toronto Stock Exchange as XNDU the following day. By going public, Xanadu positioned itself as a pure-play photonic quantum computing company—its tech relies on light-based systems, not the superconducting or trapped-ion approaches favored by some competitors.
Wednesday evening’s filing revealed more about who owns what. Radical Ventures II GP Inc. disclosed holding 11.9 million shares, which works out to 21.56% of the class. According to the document, those are Class A multiple voting shares—convertible into Class B subordinate voting shares, one-to-one.
Xanadu, on the operations front, said earlier this week it’s teaming up with EV Group to work on heterogeneous integration and wafer-bonding techniques. In chipmaking, that means bringing together materials like silicon and lithium niobate on a single chip. “Heterogeneous integration is the key” to boosting photonic performance, CEO Christian Weedbrook said. PR Newswire
This setup isn’t one-way traffic. According to the prospectus, selling holders could offload any amount of the registered shares—or hang on to them—so it’s not clear how much extra stock might actually hit the market. The filing spells out: Old Xanadu posted $4.6 million in revenue and a net loss of $70.7 million for 2025. Management, meanwhile, expects the cash from the SPAC transaction and PIPE to cover operating needs for no less than 12 months.
The quantum trade remains choppy. IonQ lifted its 2026 revenue outlook this week, but the stock slipped after results. D.A. Davidson’s Alex Platt told Reuters there’s still “skepticism” around the company’s trapped-ion tech. That method harnesses charged atomic particles with lasers. Xanadu, by contrast, leans on photons—particles of light. Reuters
With the XNDX rollout, Tradr is slotting Xanadu in alongside a handful of other speculative quantum names in the ETF space. The company says this latest fund builds on its current leveraged quantum lineup, which already covers D-Wave Quantum and Rigetti Computing, among other players. “Strong investor appetite” is how Matt Markiewicz, Tradr’s head of product and capital markets, sums up the draw for this theme. PR Newswire
Xanadu’s public-funding story surfaced in March, when the company disclosed it was in talks with both the Canadian and Ontario governments for as much as C$390 million to back Project OPTIMISM—a planned manufacturing effort. That support, Xanadu noted, still hinges on due diligence and securing final agreements.
The immediate market focus: Can Xanadu’s manufacturing pacts and access to public-market funding offset a looming wave of potential resales and the uptick in leveraged trading? Investors might get clarity not from fresh headlines, but in the numbers—if volume starts to tell the story.
